I'm sure those who can afford waiting few years, will wait. Not so sure they are the majority among diagnosed patients.
The majority of HCV patients which I referenced were the asymptomatic cases but I have no hard data to back up my assumption. The chronic patients, most of which are treatment-experienced patients having failed Peg/Riba alone, should most certainly be treated with currently available triple therapy.
News 
Market Data 
Discover 
